A high-frequency QCM biosensing platform for label-free detection of the SARS-CoV-2 spike receptor-binding domain: an aptasensor and an immunosensor-Reference-Cited by-同舟云学术

A high-frequency QCM biosensing platform for label-free detection of the SARS-CoV-2 spike receptor-binding domain: an aptasensor and an immunosensor

Published:2023 Issue:4 Volume:148 Page:719-723
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Zhang Qingqing¹,Liu Shuping²,Zhang Xiaohua¹^ORCID,Du Cuicui¹,Si Shihui²,Chen Jinhua¹^ORCID

Affiliation:

1. State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, P. R. China

2. College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, P. R. China

Abstract

High-frequency quartz crystal microbalance biosensing platforms were constructed using an aptamer and antibody as bioreceptors for fast and label-free SARS-CoV-2 RBD assay.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/AN/D3AN00008G

Reference45 articles.

1. COVID‐19 and influenza H1N1: A dangerous combination for Pakistan in the upcoming winter season

2. Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients

3. SARS-CoV-2 and influenza virus co-infection